| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP &Chief Scientific Officer
1 company
Doberstein Stephen K is a SVP &Chief Scientific Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 1 buy and 12 sells.
Estimated insider holdings value: $7.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2019 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Buy | 15,000 | $17.28 | $259,200.00 | +16.2% | |
| Aug 16, 2019 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 3,245 | $18.15 | $58,896.75 | -3.4% | |
| May 16, 2019 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 3,461 | $31.37 | $108,571.57 | -3.5% | |
| Feb 19, 2019 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 3,310 | $42.39 | $140,310.90 | -3.2% | |
| Nov 16, 2018 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 4,524 | $38.25 | $173,043.00 | -5.4% | |
| May 16, 2018 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 3,435 | $83.39 | $286,444.65 | -5.1% | |
| Apr 9, 2018 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sale+OE | 160,000 | $93.06 | $14,890,180.00 | -54.3% | |
| Feb 16, 2018 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 2,426 | $82.94 | $201,212.44 | -3.5% | |
| Nov 8, 2017 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sale+OE | 396,323 | $29.00 | $11,493,475.74 | -80.9% | |
| Oct 5, 2017 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sale+OE | 43,677 | $24.97 | $1,090,614.69 | -58.4% |